ArticleMolecular neurobiology2026
Autologous Neural Stem Cell Encapsulation in CT04-Integrated Fibrin Hydrogel Enhances Tissue Regeneration After Spinal Cord Injury in Monkeys.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord injury (SCI) is a major traumatic insult that leads to significant motor and sensory impairments. Following SCI, an inhibitory microenvironment develops, accompanied by substantial neuronal loss. A single therapeutic approach may not achieve substantial functional recovery. Therefore, strategies aimed at addressing the inhibitory environment and enhancing cellular engraftment are crucial for optimal recovery. In this study, we investigated the efficacy of combining an injectable fibrin hydrogel with subventricular zone-derived neural stem cells (SVZ-NSCs) and CT04, a RhoA inhibitor, in a rhesus monkey model of SCI. After characterizing SVZ-NSCs and optimizing the CT04 dosage, we administered the combination therapy during the sub-acute phase of SCI. Our results indicated that this combination treatment significantly improved neuronal differentiation and integration of grafted NSCs and promoted axonal regeneration. Compared to cell transplantation or CT04 treatment alone, animals receiving the combination therapy exhibited superior functional recovery. These findings highlight a promising approach for treating SCI by combining therapies to enhance NSC transplantation and axonal repair using an advanced injectable hydrogel.
Indexed as
Identifiers
41874775What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.